All News

Just over a year since AstraZeneca announced topline results, the FDA has approved a label expansion to include reducing cardiovascular (CV) death and heart failure–related hospitalizations for dapagliflozin (Farxiga) based on results of the phase 3 DELIVER trial.

The task force was motivated by a gap between in breast cancer deaths between Black and White women.

A panel on women’s health disparities at the 2023 Asembia Specialty Pharmacy Summit addressed the current challenges women face regarding health care as well as how digital tools, collaboration between clinics and governments, and more detailed and inclusive research can help improve health equity for all women.

The findings support policies urging vaccination of individuals who have myasthenia gravis (MG).

The end of the COVID-19 public health emergency spotlights US outbreak tracking weakness; the American Psychological Association released guidelines to guide teen social media use; the first study funded by the US government to measure safe injection site effectiveness was announced Monday.

The relationship between myopia and primary open-angle glaucoma (POAG) was stronger in Asian, Black, and Hispanic individuals compared with White individuals.

China’s National Medical Products Administration has approved 2 supplemental new drug applications of zanubrutinib for use in untreated adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma and Waldenström macroglobulinemia.

The prevalence of Clostridioides difficile has risen in recent years, and although its carriage is recognized in infancy, limited data exist on its longitudinal trends.

This longitudinal analysis of claims data examined changes in telehealth and in-person delivery of services in Louisiana.

In addition to current available risk scores, the new system can help counsel patients with myelofibrosis (MF) undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT), authors wrote.

Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.

Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, discusses how CRISPR technology has seen success and potential areas for future application.

Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the role the new wave of biosimilars will have on rebate practices for both pharmacy benefit managers (PBMs) and payers.

Treatment options have improved care, but also increased the need for patient education.

A study found that not being infected with respiratory syncytial virus (RSV) in the first year of life was associated with a decreased risk of developing asthma in childhood.

The possible consequences for health care if the United States breaches the debt ceiling; skepticism follows proposal for over-the-counter birth control pill; North Carolina governor calls potential abortion ban harmful.

After winning our Seema S. Sonnad Emerging Leader in Managed Care Research Award, these researchers have gone on to make substantial impacts in the field of managed care and mentor the next generation of investigators.

Cost sharing for several treatments could disappear following the Braidwood v Becerra ruling, according to A. Mark Fendrick, MD, director of the V-BID Center at the University of Michigan and co-editor in chief of The American Journal of Managed Care®.

Common treatments for acne are known to be unsafe for pregnant women, but alternative treatments exist that are safe for use; however, actual treatment patterns within this patient population are unclear.

To address the research gap in familial focal epilepsy with variable foci (FFEVF), investigators assessed the clinical features of a family with FFEVF that included 4 patients in 3 generations and 1 healthy member.

How much does education about the specific risks of smoking assist in smoking cessation?

A recent survey assessed the factors that adult patients with eczema and caregivers find important regarding clinical trial participation decision-making.

Previous research has shown household food insecurity is linked with poor dietary intake, but research specific to those with diabetes has been sparse.

Dupilumab treatment delivered at a specialized tertiary care center has great potential to improve patient clinical outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP).

Fecal microbiota transplantation (FMT) has emerged as a highly successful therapeutic strategy for recurrent Clostridioides difficile infection (CDI) in recent years.

For Brain Cancer Awareness Month, AJMC shares an interview with Day One Biopharmaceuticals CEO Jeremy Bender, PhD, MBA. Bender discussed the company's lead agent, tovorafenib, which has shown promise in treatment of pediatric low-grade glioma.

Steven Heatherly of Baptist Health in Kentucky talks about the success of heart clinics and promising results from remote patient monitoring.

An expert panel at the recent meeting of the Quality Cancer Care Alliance discussed the Enhancing Oncology Model (EOM), which is set to begin on July 1, 2023.